First Clinical Study with AP30663 ‐ a KCa2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
暂无分享,去创建一个
U. Sørensen | J. Burggraaf | M. Grunnet | E. Klaassen | B. Bentzen | M. Kemme | P. Gal | K. Bergmann | N. Edvardsson | Mahdi Saghari | Christina Sylvest | J. G. Diness